[1]Patent:CN107488167,2017,A,
[1]BioorganicandMedicinalChemistryLetters,1999,vol.9,p.1625-1630
[2]Patent:WO2011/50962,2011,A1
[3]Patent:WO2011/111053,2011,A1
[4]Patent:WO2013/5229,2013,A1
[5]ChemistryofHeterocyclicCompounds,2015,vol.51,p.133-138 Khim.Geterotsikl.Soedin.,2015,vol.51,p.133-138,6
[6]BioorganicandMedicinalChemistryLetters,2017,vol.27,p.4075-4081
[7]Patent:CN108218833,2018,A
[8]Patent:WO2018/140809,2018,A1
[9]Patent:US2018/334443,2018,A1
[10]Patent:CN109776493,2019,A
[11]Patent:WO2019/207538,2019,A1
[12]Patent:CN110407807,2019,A
[13]Patent:CN110642834,2020,A
[1]BioorganicandMedicinalChemistryLetters,1999,vol.9,p.1625-1630
[2]Patent:WO2013/5229,2013,A1
[3]Patent:CN109776493,2019,A
[1]BioorganicandMedicinalChemistryLetters,1999,vol.9,p.1625-1630
[2]Patent:CN109776493,2019,A
[1]Patent:WO2005/5409,2005,A1.Locationinpatent:Page/Pagecolumn7
[1]Patent:WO2005/5409,2005,A1.Locationinpatent:Page/Pagecolumn7
[2]Patent:WO2005/5409,2005,A1.Locationinpatent:Page/Pagecolumn8
Title: Angiogenesis inhibitors derived from thalidomide.
Journal: Bioorganic & medicinal chemistry letters 20051215